Unlv, Basketball team

A recent study has given a new ray of hope by showing that science is getting one step closer to developing targeted drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.Research led by a team of UNLV neuroscientists has shown the potential to zero in on the root-level cause of a host of adverse symptoms associated with unique subtypes of neurodevelopmental disorders, work that could one day improve the lives of millions worldwide. The study was published in the 'Nature' journal, 'Molecular Psychiatry'.It built on previous research by UNLV neuroscientist Rochelle Hines and collaborators, which discovered that two key proteins -- collybistin and the GABAA receptor a2 subunit -- controlled the firing of brain cells and contributed to epileptic seizures, learning and memory deficiencies, sleep disturbances, and other symptoms frequently associated with various forms of intellectual disability including Down syndrome, autism, and ADHD.The team's newest findings unveiled that mutations in ARHGEF9 -- the gene that codes for collybistin -- lead to intellectual disability through impaired a2 subunit function. The team further showed that a2 was a central hub for many of the adverse neurological symptoms characteristic of multiple intellectual disability subtypes."Seizures and sleep deficits are two of the most common and most disruptive symptoms in children with neurodevelopmental disorders, and sleep deficits in particular are not well treated and can impact the entire family," said Hines, who partnered with UNLV faculty and undergraduate and graduate student researchers, as well as scientists from Tufts University and Boston Children's Hospital. "This research gives new hope to patients that we can now develop drug therapies and provide more precise interventions."In addition to patients with neurodevelopmental disorders, researchers said their study had the potential to improve the quality of life more broadly for people who grapple with sleep dysfunction, epilepsy, anxiety, hyperactivity, and other neurological abnormalities.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Trump Tarrifs

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

UnlvFOLLOW

Unlv, Latest News

Health :Study: Gut health may affect probability of acquiring Alzheimer's in brain

Las Vegas [US], May 12 : Could altering your diet help to delay the onset of dementia or perhaps ... ...

Technology :Study shines new light on ancient microbial dark matter

Las Vegas [US], March 18 : Bacteria are practically found everywhere, including in dirt, hot springs, oceans, and even ... ...

Technology :Researchers discover a new form of ice

Researchers have discovered a new form of ice, which could have implications for our understanding of distant, water-rich planets. ...

Technology :Science is getting closer to reduce seizures in intellectually disabled: Study

Science is getting one step closer to developing drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities. ...

Technology :Research shows science getting closer to reduce seizures, sleep disturbances in intellectually disabled

A recent study has given a new ray of hope by showing that science is getting one step closer to developing targeted drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities. ...